Bacitracin EP Impurity B Tritrifluoroacetate
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-B001-004
- Formula
- C64H99N17O16S·3C2HF3O2
- Family
- Bacitracin
Pharmaceutical analytical standards
APIs, pharmacopoeial impurities, metabolites, nitrosamines and labelled standards.
Results 12,281-12,290 of 59,523
Bacitracin EP Impurity M
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-B001-051
- Formula
- C66H101N17O16S
- Family
- Bacitracin
- Synonyms
- Bacitracin Y
Bacitracin Impurity 10
ImpurityLevels of characterisation
- Cat. No.
- P-B001-050
- Formula
- C9H16N2O2S
- Family
- Bacitracin
Bacitracin Impurity 4
ImpurityLevels of characterisation
- Cat. No.
- P-B001-041
- Formula
- C23H24N2O4S
- Family
- Bacitracin
Bacitracin Impurity 8
ImpurityLevels of characterisation
- Cat. No.
- P-B001-045
- Formula
- C13H22N2O4S
- Family
- Bacitracin
- Synonyms
- (4R)-2-[(1S)-2-Methyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-4,5-dihydro-1,3-thiazole-4-carboxylic acid
rac-Carbidopa EP Impurity C Trifluoroacetate
Pharmacopoeial impurityLevels of characterisation
- Cat. No.
- P-C037-013
- Formula
- C11H16N2O4·C2HF3O2
- Family
- Carbidopa
- Synonyms
- Carbidopa USP Related Compound A Trifluoroacetate
Carbidopa Impurity 2 Hydrobromide
ImpurityLevels of characterisation
- Cat. No.
- P-C037-027
- Formula
- C9H8N2O2·HBr
- Family
- Carbidopa
- Synonyms
- 3-Methylcinnoline-6,7-diol hydrobromide
Carbidopa Impurity 3
ImpurityLevels of characterisation
- Cat. No.
- P-C037-028
- Formula
- C14H20N2O4
- Family
- Carbidopa
- Synonyms
- Methyl (2S)-3-(3,4-dihydroxyphenyl)-2-methyl-2-(2-propan-2-ylidenehydrazinyl)propanoate
rac-Carbidopa Impurity H
ImpurityLevels of characterisation
- Cat. No.
- P-C037-032
- Formula
- C11H16N2O4
- Family
- Carbidopa
Carbidopa-d6
Isotopically labelledLevels of characterisation
- Cat. No.
- P-C037-018
- Formula
- C10H8D6N2O4
- Family
- Carbidopa
No product found: try the CAS, the code or a shorter name, or write to us and we will look for it.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.